563
Views
40
CrossRef citations to date
0
Altmetric
Review

Cognitive impairment in patients with AIDS – prevalence and severity

&
Pages 35-47 | Published online: 29 Jan 2015

References

  • UNAIDS2013 UNAIDS Report on the Global AIDS Epidemic2013 Available form: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdfAccessed May 27, 2013
  • Center for Disease Control (CDC)HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent AreasAtlanta, GAUS Department of Health and Human Services, CDC2005 [online]Atlanta, GAUS Department of Health and Human Services, CDC2011
  • SimoneMJAppelbaumJHIV in older adultsGeriatrics2008631261219061274
  • NguyenNHolodniyMHIV infection in the elderlyClin Interv Aging20083345347218982916
  • ZablotskyDKennedyMRisk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practicesJ Acquir Immune Defic Syndr200333Suppl 2S122S13012853861
  • ButtAMNandwaniRSexually transmitted diseases in HIV-1-infected patientsLancet20013579267153311386292
  • McArthurJCSacktorNSelnesOHuman immunodeficiency virus-associated dementiaSemin Neurol199919212915010718534
  • JusticeACMcGinnisKAAtkinsonJHPsychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site StudyAIDS200418Suppl 1S49S5915075498
  • GoodkinKWilkieFLConchaMAging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortalityJ Clin Epidemiol200154Suppl 1S35S4311750208
  • ValcourVShikumaCShiramizuBHigher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 CohortNeurology200463582282715365130
  • JanssenRSSt LouisMESattenGAHIV infection among patients in US acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance GroupN Engl J Med199232774454521625734
  • AntinoriAArendtGBeckerJTUpdated research nosology for HIV-associated neurocognitive disordersNeurology200769181789179917914061
  • HRSAHIV-Associated Dementia and Other Neurocognitive DisordersGuide for HIV/AIDS Clinical Care, 2014 Available from: http://hab.hrsa.gov/deliverhivaidscare/2014guide.pdfAccessed October 27, 2014
  • CrossSOnenNGaseAOvertonETAncesBMIdentifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scaleJ Neuroimmune Pharmacol2013851114112224114509
  • HavlikRJBrennanMKarpiakSEComorbidities and depression in older adults with HIVSex Health20118455155922127042
  • SonnevilleRFerrandHTubachFNeurological complications of HIV infection in critically ill patients: clinical features and outcomesJ Infect201162430130821329724
  • FernandezFLevyJKSamleyHREffects of methylphenidate in HIV-related depression: a comparative trial with desipramineInt J Psychiatry Med199525153677649718
  • InouyeSKDelirium in hospitalized older patients: recognition and risk factorsJ Geriatr Psychiatry Neurol199811Fall 3118125 discussion 157–1589894730
  • PerrySMarottaRFAIDS dementia: a review of the literatureAlzheimer Dis Assoc Disord1987142212353331119
  • AngelinoAFTreismanGJIssues in co-morbid severe mental illnesses in HIV infected individualsInt Rev Psychiatry20082019510118240066
  • UldallKKBerghuisJPDelirium in AIDS patients: recognition and medication factorsAIDS Patient Care STDS199711643544111361865
  • UldallKKHarrisVLLalondeBOutcomes associated with delirium in acutely hospitalized acquired immune deficiency syndrome patientsCompr Psychiatry2000412889110741884
  • UldallKKRyanRBerghuisJPHarrisVLAssociation between delirium and death in AIDS patientsAIDS Patient Care STDS20001429510010743522
  • HatherillSFlisherADelirium in children with HIV/AIDSJ Child Neurol200924787988319299649
  • HillLLeeKCPharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychoticsAnn Pharmacother2013471758923341158
  • CandyBJacksonKCJonesLLeurentBTookmanAKingMDrug therapy for delirium in terminally ill adult patientsCochrane Database Syst Rev201211CD00477023152226
  • BreitbartWMarottaRPlattMMA double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patientsAm J Psychiatry199615322312378561204
  • BreitbartWRosenfeldBKaimMFunesti-EschJA randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus diseaseArch Intern Med2001161341142011176767
  • SeitzDPGillSSvan ZylLTAntipsychotics in the treatment of delirium: a systematic reviewJ Clin Psychiatry2007681112117284125
  • ValcourVWattersMRWilliamsAESacktorNMcMurtrayAShikumaCAging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapyJ Neurovirol200814536236718989814
  • KellyDVBeiqueLCBowmerMIExtrapyramidal symptoms with ritonavir/indinavir plus risperidoneAnn Pharmacother200236582783011978161
  • DolderCRPattersonTLJesteDVHIV, psychosis and aging: past, present and futureAIDS200418Suppl 1S35S4215075496
  • FernandezFLevyJKMansellPWManagement of delirium in terminally ill AIDS patientsInt J Psychiatry Med19891921651722681028
  • ItohKMehraeinPWeisSNeuronal damage of the substantia nigra in HIV-1 infected brainsActa Neuropathol200099437638410787036
  • FerrandoSJWapenyiKPsychopharmacological treatment of patients with HIV and AIDSPsychiatr Q200273Spring 1334911780596
  • CarricoAWJohnsonMOMorinSFCorrelates of suicidal ideation among HIV-positive personsAIDS20072191199120317502730
  • LesoLSchwartzTLZiprasidone treatment of deliriumPsychosomatics2002431616211927760
  • CysiqueLADeutschRAtkinsonJHIncident major depression does not affect neuropsychological functioning in HIV-infected menJ Int Neuropsychol Soc200713111117166298
  • GibbieTHayMHutchisonCWMijchADepression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDSSex Health20074422723218082064
  • CieslaJARobertsJEMeta-analysis of the relationship between HIV infection and risk for depressive disordersAm J Psychiatry2001158572573011329393
  • LyketsosCGHooverDRGuccioneMDepressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort StudyJAMA199327021256325677901432
  • WatkinsCCTreismanGJNeuropsychiatric complications of aging with HIVJ Neurovirol201218427729022644745
  • RabkinJGWagnerGJMcElhineyMCRabkinRLinSHTestosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo- controlled trialJ Clin Psychopharmacol200424437938515232328
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, 4th Edition – Text Revision (DSMIV-TR)Washington, DCAmerican Psychiatric Association2000
  • WatkinsCCPieperAATreismanGJSafety considerations in drug treatment of depression in HIV-positive patients: an updated reviewDrug Saf201134862363921751824
  • Nakimuli-MpunguEMusisiSKatabiraENachegaJBassJPrevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern UgandaJ Affect Disord20111351–316016721851986
  • SledjeskiEMDelahantyDLBogartLMIncidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIVAIDS Patient Care STDS2005191172873616283833
  • TsaiACMimiagaMJDilleyJWDoes effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trialAIDS Behav20131782765277223975476
  • TreismanGJAngelinoAFHuttonHEPsychiatric issues in the management of patients with HIV infectionJAMA2001286222857286411735762
  • HimelhochSBrownCHWalkupJHIV patients with psychiatric disorders are less likely to discontinue HAARTAIDS200923131735174219617816
  • AlciatiAGalloLMonforteADBrambillaFMelladoCMajor depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patientsHum Psychopharmacol2007221334017191264
  • IckovicsJRHamburgerMEVlahovDMortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research StudyJAMA2001285111466147411255423
  • LyketsosCGHooverDRGuccioneMChanges in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort StudyAm J Psychiatry199615311143014378890676
  • SherrLHardingRLampeFClinical and behavioural aspects of aging with HIV infectionPsychol Health Med200914327327919444705
  • MaoYGeXFrankCLDisrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signalingCell200913661017103119303846
  • HirshfieldSWolitskiRJChiassonMARemienRHHumberstoneMWongTScreening for depressive symptoms in an online sample of men who have sex with menAIDS Care200820890491018720088
  • LyketsosCGHansonAFishmanMMcHughPRTreismanGJScreening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presenceInt J Psychiatry Med19942421031137960418
  • CliffordDBEvansSYangYImpact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsAnn Intern Med20051431071472116287792
  • JournotVCheneGDe CastroNUse of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099Clin Infect Dis200642121790179916705588
  • CliffordDBEvansSYangYAcostaEPRibaudoHGulickRMLong-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)HIV Clin Trials200910634335520133265
  • FerrandoSJFreybergZTreatment of depression in HIV positive individuals: a critical reviewInt Rev Psychiatry2008201617118240063
  • AkenaDSteinDJJoskaJDoes screening HIV-positive individuals in Uganda for major depressive disorder improve case detection rates and antidepressant prescription?AIDS Behav20121782802280723247361
  • HuangTLLeuHSLiuJWLymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic studyPsychiatry Clin Neurosci200660668769217109702
  • HarezlakJBuchthalSTaylorMPersistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatmentAIDS201125562563321297425
  • RabkinJGRabkinRHarrisonWWagnerGEffect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illnessAm J Psychiatry199415145165237908501
  • RabkinJGRabkinRWagnerGEffects of fluoxetine on mood and immune status in depressed patients with HIV illnessJ Clin Psychiatry199455392977915270
  • RabkinJGWagnerGJRabkinRFluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trialAm J Psychiatry199915611011079892304
  • TsaiACKarasicDHHammerGPDirectly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trialAm J Public Health2012103230831522720766
  • ZisookSPeterkinJGogginKJSledgePAtkinsonJHGrantITreatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center GroupJ Clin Psychiatry19985952172249632030
  • TsaiACWeiserSDPetersenMLRaglandKKushelMBBangsbergDRA marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVArch Gen Psychiatry201067121282129021135328
  • KumarVEncinosaWEffects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patientsPsychiatr Q200980313114119387832
  • SchroecksnadelKSarclettiMWinklerCQuality of life and immune activation in patients with HIV-infectionBrain Behav Immun200822688188918261883
  • SevignyJJAlbertSMMcDermottMPEvaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementiaNeurology200463112084209015596754
  • PriceRWBrewBSidtisJRosenblumMScheckACClearyPThe brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complexScience198823948405865923277272
  • KoutsilieriESopperSSchellerCTer MeulenVRiedererPParkinsonism in HIV dementiaJ Neural Transm20021095–676777512111466
  • KoutsilieriESopperSSchellerCTer MeulenVRiedererPInvolvement of dopamine in the progression of AIDS dementia complexJ Neural Transm2002109339941011956960
  • MirsattariSMPowerCNathAParkinsonism with HIV infectionMov Disord19981346846899686775
  • HrisoEKuhnTMasdeuJCGrundmanMExtrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathyAm J Psychiatry199114811155815611681751
  • DunlopOBjørklundRBruunJNEarly psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitisActa Neurol Scand2002105427027512004769
  • LetendreSLEllisRJAncesBMMcCutchanJANeurologic complications of HIV disease and their treatmentTop HIV Med2007182455520516524
  • LevineAJHinkinCHAndoKAn exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adultsJ Clin Exp Neuropsychol200830783684318608693
  • KoskiLBrouilletteMJLalondeRComputerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment (*)HIV Med201112847248021395965
  • WagnerGJRabkinREffects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trialJ Clin Psychiatry200061643644010901342
  • NaviaBAPriceRWThe acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infectionArch Neurol198744165693800724
  • McArthurJCHooverDRBacellarHDementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort StudyNeurology19934311224522528232937
  • SacktorNMcDermottMPMarderKHIV-associated cognitive impairment before and after the advent of combination therapyJ Neurovirol20028213614211935465
  • SacktorNThe epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapyJ Neurovirol20028Suppl 211512112491162
  • BhaskaranKMussiniCAntinoriAChanges in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapyAnn Neurol200863221322117894380
  • SternYMcDermottMPAlbertSFactors associated with incident human immunodeficiency virus-dementiaArch Neurol200158347347911255452
  • TozziVBalestraPLorenziniPPrevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohortJ Neurovirol200511326527316036806
  • BolokadzeNGabuniaPEzugbaiaMGatsereliaLKhechiashviliGNeurological complications in patients with HIV/AIDSGeorgian Med News2008165343819124914
  • WojnaVSkolaskyRLHechavarríaRPrevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairmentJ Neurovirol200612535636417065128
  • JowiJOMativoPMMusokeSSClinical and laboratory characteristics of hospitalised patients with neurological manifestations of HIV/AIDS at the Nairobi hospitalEast Afr Med J2007842677617598667
  • HeatonRKCliffordDBFranklinDRJrHIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyNeurology201075232087209621135382
  • McArthurJCSteinerJSacktorNNathAHuman immunodeficiency virus-associated neurocognitive disorders: Mind the gapAnn Neurol201067669971420517932
  • FinziDHermankovaMPiersonTIdentification of a reservoir for HIV-1 in patients on highly active antiretroviral therapyScience19972785341129513009360927
  • AnthonyICRamageSNCarnieFWSimmondsPBellJEInfluence of HAART on HIV-related CNS disease and neuroinflammationJ Neuropathol Exp Neurol200564652953615977645
  • AnthonyICRamageSNCarnieFWSimmondsPBellJEDoes drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?Neuropathol Appl Neurobiol200531332533815885069
  • CysiqueLABrewBJNeuropsychological functioning and antiretroviral treatment in HIV/AIDS: a reviewNeuropsychol Rev200919216918519424802
  • Gonzalez-ScaranoFMartin-GarciaJThe neuropathogenesis of AIDSNat Rev Immunol200551698115630430
  • KaulMHIV’s double strike at the brain: neuronal toxicity and compromised neurogenesisFront Biosci2008132484249417981728
  • HeatonRKFranklinDREllisRJHIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsJ Neurovirol201017131621174240
  • DoreGJCorrellPKLiYKaldorJMCooperDABrewBJChanges to AIDS dementia complex in the era of highly active antiretroviral therapyAIDS199913101249125310416530
  • SkinnerSAdewaleAJDeBlockLGillMJPowerCNeurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapyHIV Med200910424625219187172
  • HasbunRErasoJRamireddySScreening for neurocognitive impairment in HIV individuals: the utility of the Montreal Cognitive Assessment TestJ AIDS Clin Res201331018623956944
  • GandhiNSMoxleyRTCreightonJComparison of scales to evaluate the progression of HIV-associated neurocognitive disorderHIV Ther20104337137920824119
  • DavisHFSkolaskyRLJrSelnesOABurgessDMMcArthurJCAssessing HIV-associated dementia: modified HIV dementia scale versus the Grooved PegboardAIDS Read200212129313811862658
  • OshinaikeOOAkinbamiAAOjoOOOjiniIFOkubadejoUNDanesiAMComparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral TherapyAIDS Res Treat2012201258153123050130
  • DescampsMHyareHZerizerIJ A GerHNeuroimaging of CNS involvement in HIVJ HIV Ther2008133485419039295
  • RocACAncesBMChawlaSDetection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapyArch Neurol20076491249125717620480
  • ThurnherMMSchindlerEGThurnherSAPernerstorfer-SchonHKleibl-PopovCRiegerAHighly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical courseAJNR Am J Neuroradiol200021467067810782776
  • DescampsMHyareHStebbingJWinstonAMagnetic resonance imaging and spectroscopy of the brain in HIV diseaseJ HIV Ther2008133555819039299
  • SundgrenPCDongQGomez-HassanDMukherjiSKMalyPWelshRDiffusion tensor imaging of the brain: review of clinical applicationsNeuroradiology200446533935015103435
  • ChangLLeePLYiannoutsosCTA multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to ageNeuroimage20042341336134715589098
  • MohamedMABarkerPBSkolaskyRLBrain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy studyMagn Reson Imaging20102891251125720688449
  • YiannoutsosCTErnstTChangLRegional patterns of brain metabolites in AIDS dementia complexNeuroimage200423392893515528093
  • MeyerhoffDJMacKaySBachmanLReduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imagingNeurology1993433 pt 15095158450992
  • ErnstTChangLJovicichJAmesNArnoldSAbnormal brain activation on functional MRI in cognitively asymptomatic HIV patientsNeurology20025991343134912427881
  • SchifittoGKieburtzKMcDermottMPClinical trials in HIV-associated cognitive impairment: cognitive and functional outcomesNeurology200156341541811171916
  • UthmanOAAbdulmalikJOAdjunctive therapies for AIDS dementia complexCochrane Database Syst Rev20083CD00649618646159
  • Robinson-PappJElliottKJSimpsonDMHIV-related neurocognitive impairment in the HAART eraCurr HIV/AIDS Rep20096314615219589300
  • TozziVBalestraPSerrainoDNeurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAARTAIDS Res Hum Retroviruses200521870671316131310
  • WinstonAPulsRKerrSJDynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled studyHIV Med201113424525122151608
  • RourkeSBHalmanMHBasselCNeurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioningJ Clin Exp Neuropsychol199921673775610649531
  • HeseltinePNGoodkinKAtkinsonJHRandomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairmentArch Neurol199855141519443710
  • ConsortiumDA randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive DisordersNeurology19985036456519521250
  • SchifittoGNaviaBAYiannoutsosCTAdult AIDS Clinical Trial Group (ACTG) 301, 700 Teams, HIV MRS ConsortiumMemantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy studyAIDS200721141877188617721095
  • KieburtzKDGiangDWSchifferRBVakilNAbnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunctionArch Neurol19914833123141848071
  • MintzMTardieuMHoytLMcSherryGMendelsonJOleskeJLevodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromesNeurology1996476158315858960752
  • HinkinCHCastellonSAHardyDJFarinpourRNewtonTSingerEMethylphenidate improves HIV-1-associated cognitive slowingJ Neuropsychiatry Clin Neurosci200113Spring 224825411449032
  • CzubSKoutsilieriESopperSEnhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugsActa Neuropathol20011012859111271377
  • DettlingMMuller-OerlinghausenBBritschPClozapine treatment of HIV-associated psychosis – too much bone marrow toxicity?Pharmacopsychiatry19983141561579754853
  • ZilikisNNimatoudisIKiossesVIerodiakonouCTreatment with risperidone of an acute psychotic episode in a patient with AIDSGen Hosp Psychiatry19982063843859854654